SCHEMBL9765618

SCHEMBL9765618

c1ccc(-c2ccc(Cn3cccc3)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 5/20 0.61
CYP11B2 P19099 5/20 0.61
CYP17A1 P05093 1/20 0.61
FAAH O00519 1/20 0.52
MGLL Q99685 1/20 0.52
CYP19A1 P11511 2/20 0.49
TAAR1 Q96RJ0 2/20 0.48
HDAC6 Q9UBN7 2/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC1 Q13547 1/20 0.47
GRM2 Q14416 1/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2C19 P33261 1/20 0.44
CYP1A2 P05177 1/20 0.44
POLB P06746 1/20 0.44
CYP3A4 P08684 1/20 0.44
MAPT P10636 1/20 0.44
TBXAS1 P24557 1/20 0.44
QPCT Q16769 1/20 0.44
CYP4Z1 Q86W10 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL35352 0.85 CYP19A1 (0.56) CYP11B1CYP11B2CYP17A1MGLLCYP19A1
Bromide SCHEMBL916244 0.83 CYP19A1 (0.54) CYP11B1CYP11B2CYP17A1MGLLCYP19A1
Hydrochloric Acid SCHEMBL27713045 0.83 CYP19A1 (0.54) CYP11B1CYP11B2CYP17A1MGLLCYP19A1
SCHEMBL27828239 0.83 CYP19A1 (0.54) CYP11B1CYP11B2CYP17A1MGLLCYP19A1
SCHEMBL6695778 0.77 MAPK1 (0.50) CYP11B1CYP11B2CYP17A1MGLLCYP19A1
SCHEMBL2033990 0.77 CYP11B1 (1.00) CYP11B1CYP11B2CYP17A1CYP19A1CYP2D6
SCHEMBL10878922 0.76 NPC1 (0.63) CYP11B1CYP11B2CYP19A1TAAR1HDAC6
SCHEMBL6057565 0.76 HDAC1 (0.50) CYP11B1CYP11B2CYP17A1MGLLCYP19A1
SCHEMBL15761419 0.75 CYP11B1 (0.70) CYP11B1CYP11B2
SCHEMBL15201955 0.74 HDAC1 (0.48) CYP11B1CYP11B2MGLLCYP19A1TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104262228-B Neutral endopeptidase inhibitor intermediate and preparation method thereof 诺华股份有限公司 2017-01-18 CN disclosed
US-5041554-A Replace steroids in treatment of inflammatory diseases MERRELL DOW PHARMACEUTICALS INC. (US) 1991-08-20 US disclosed
US-5039695-A Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions MERRELL DOW PHARMACEUTICALS INC. (US) 1991-08-13 US disclosed